Target intelligence / Profile preview

Influenza A virus hemagglutinin stalk region (HA stalk)

Target
HA stalk
Molecular classification
Viral surface glycoprotein, Class I fusion protein, Antigen
01

Overview

The Influenza A virus hemagglutinin (HA) stalk region is a critical, highly conserved component of the virus's primary surface glycoprotein, which is essential for host cell entry. While the globular head of the HA protein undergoes frequent antigenic drift, the stalk region remains relatively stable across diverse influenza A subtypes, including H1 and H5 (PMID: 22878502). Biologically, the stalk functions as a molecular spring that, upon exposure to the acidic environment of the endosome, undergoes a dramatic conformational change to facilitate the fusion of the viral and host membranes (UniProt: P03452). This fusion process is vital for the release of the viral ribonucleoprotein complex into the host cytoplasm. Therapeutic strategies targeting the HA stalk, such as broadly neutralizing monoclonal antibodies like MedI8852 and universal vaccine candidates, aim to block this conformational shift or sterically hinder the fusion machinery (PMID: 26912702). Consequently, the HA stalk is a focal point for developing broad-spectrum countermeasures against both seasonal and pandemic influenza threats (PMID: 23303906).

Other names
Hemagglutinin stem regionHA2 subunitConserved stalk domainHA stalk domainHemagglutinin fusion domain
02

Mechanism of action

Binding to the conserved stalk region prevents the pH-triggered conformational change required for the fusion of the viral envelope with the host endosomal membrane, thereby blocking viral entry into the host cell.

03

Biological functions

Viral entryMembrane fusionViral attachment
04

Disease associations

Influenza A infection
05

Safety considerations

Low immunogenicity compared to the head domainPotential for viral escape mutationsTheoretical risk of antibody-dependent enhancement (ADE)Subtype-specific limitations of some antibodies
06

Interacting drugs

Umifenovir

5 more in the full profile.

07

Biomarkers

Anti-HA stalk antibody titersHA-specific B cell frequencyStalk-binding IgG levels

Beyond the preview

Go deeper on Influenza A virus hemagglutinin stalk region (HA stalk).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin stalk region (HA stalk).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call